<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00734786</url>
  </required_header>
  <id_info>
    <org_study_id>CLN 08-003</org_study_id>
    <nct_id>NCT00734786</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles</brief_title>
  <official_title>Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles. Study # CLN 08-003.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phytotox SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phytotox SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the trial is to determine whether the current topical formulation of
      GTX 2/3 reduces the wrinkling of the skin (crow's feet) after a single application

      Other evaluation criteria include: safety assessment and local tolerance, depth of facial
      wrinkles (video microscopy imaging).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single volunteer group study. Each volunteer will be her own control. A volunteer
      will receive the active product containing cream on one side of her face and will receive the
      placebo cream on the other side.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study cancelled.
  </why_stopped>
  <start_date>August 2008</start_date>
  <completion_date type="Anticipated">September 2008</completion_date>
  <primary_completion_date type="Anticipated">September 2008</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depth of facial wrinkles</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Local and general tolerance</measure>
    <time_frame>1day</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Facial Wrinkles</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Volunteers will be their own control by randomly receiving the active on one face side and the placebo on the opposite one.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wrinkle cream application</intervention_name>
    <description>Single application on the crow's feet wrinkles. Placebo cream will be applied on one side, the active cream on the other side.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>No other product will be used.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with no bearing-child potential or with adequate birth control method.

          -  Volunteers between 30 to 60 years of age.

          -  Subjects with bilateral crow's feet wrinkles.

          -  Regular user of cosmetic products, willing and able to comply with the study
             objectives.

          -  Signed informed consent.

        Exclusion Criteria:

          -  Any medical condition or any use of a medication that could modify the study results
             (e.g.: NSAIDs, immunosuppressant drugs, insulin...).

          -  Any other significant medical condition (e.g.: diabetes mellitus, heart disease, liver
             disease...).

          -  Any other condition that in the investigator's opinion could not be appropriate with
             the participation in this trial.

          -  Any health condition that could affect the evaluation of study parameters.

          -  Acute or chronic skin disease.

          -  History of allergic reaction to cosmetic compounds.

          -  Pregnancy, planned pregnancy or breast-feeding.

          -  Allergy to shellfish, fish or sea product (seaweed).

          -  Known or suspected hypersensitivity to any of the study product compounds.

          -  Participation in another clinical trial within 30 days previous to enrolment.

          -  Known or suspected alcohol or drug abuse.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvia H Pérez-Damonte, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CLAIM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CLAIM</name>
      <address>
        <city>Buenos Aires</city>
        <state>CF</state>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2008</study_first_submitted>
  <study_first_submitted_qc>August 13, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2008</study_first_posted>
  <last_update_submitted>August 22, 2008</last_update_submitted>
  <last_update_submitted_qc>August 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dra Silvia Pérez Damonte</name_title>
    <organization>CLAIM</organization>
  </responsible_party>
  <keyword>gonyautoxin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

